# Advisor Review - GPT-5.4 (R1)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-11T10:40:20.690324
**Route:** OpenRouter + LaTeX
**Paper Hash:** 91446e5b47a7c630
**Tokens:** 18603 in / 1084 out
**Response SHA256:** c1c719aec06cb8df

---

I checked the paper for fatal errors in the four requested categories only.

Findings:
- **Data-design alignment:** No fatal mismatch found. The treatment begins in **2017**, and the data cover **2012–2022** (with the main estimation sample using **2012–2019**), so treatment timing is feasible. The DiD has both pre- and post-treatment observations. Treatment definitions appear consistent across the text and tables.
- **Regression sanity:** No fatal regression-output issues found in any table. I did not find impossible values, explosive coefficients, absurd standard errors, negative SEs, R² outside \([0,1]\), or NA/NaN/Inf entries.
- **Completeness:** Regression tables report coefficients, standard errors, and sample sizes. I did not find placeholder entries like TBD/TODO/XXX/NA in tables. Referenced appendices/tables/figures cited in the LaTeX source are present by label.
- **Internal consistency:** The main numerical claims in the text match the reported regression tables (e.g., preferred estimate \(0.0101\) with SE \(0.0159\); placebo timing \(0.1844\) with SE \(0.1776\)). Sample-size differences across specifications are explained and consistent with the tables.

No fatal errors identified.

ADVISOR VERDICT: PASS